Parlodel SRO in Parkinson's disease: a double-blind randomized comparison of Parlodel standard and Parlodel SRO

In this study, we compared in an intent-to-treat analysis the tolerance and efficacy of Parlodel SRO with its standard galenic formulation in 34 patients with Parkinson's disease who received optimal levodopa therapy. The results suggest that Parlodel SRO was equally efficacious as Parlodel sta...

Full description

Saved in:

Bibliographic Details
Published in:	European neurology Vol. 32; no. 6; p. 318
Main Authors:	Jansen, E N, Staal-Schreinemachers, A, van der Sande, J J, Haas, J A, Lakke, J P
Format:	Journal Article
Language:	English
Published:	Switzerland 1992
Subjects:	Administration, Oral Aged Bromocriptine - administration & dosage Delayed-Action Preparations Double-Blind Method Drug Therapy, Combination Female Humans Levodopa - administration & dosage Male Middle Aged Neurologic Examination - drug effects Parkinson Disease - drug therapy
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	In this study, we compared in an intent-to-treat analysis the tolerance and efficacy of Parlodel SRO with its standard galenic formulation in 34 patients with Parkinson's disease who received optimal levodopa therapy. The results suggest that Parlodel SRO was equally efficacious as Parlodel standard, but Parlodel SRO is better tolerated.
ISSN:	0014-3022
DOI:	10.1159/000116852